0001193125-25-265664
SEC filingRevenue declined 7.0% in Q3 2025 due to a weaker film slate, partially offset by strategic pricing actions and international constant currency growth.
For the three months ended September 30, 2025, Cinemark reported total revenue of $857.5 million, a decrease of 7.0% compared to $921.8 million in the same period of 2024. The decline was primarily driven by a 10.3% drop in consolidated attendance to 54.2 million patrons, reflecting a film slate that did not resonate as strongly with audiences. The North American industry box office was approximately $2.5 billion in Q3 2025 versus $2.7 billion in Q3 2024. Admissions revenue fell 6.7% to $429.7 million, while concession revenue decreased 8.3% to $336.7 million. Other revenue declined 3.2% to $91.1 million.
Despite lower attendance, average ticket price increased 4.1% to $7.93 and concession revenue per patron rose 2.1% to $6.21, driven by strategic pricing actions and a higher mix of merchandise. Total cost of operations decreased to $743.1 million from $758.3 million, but as a percentage of revenue, costs rose to 86.7% from 82.3%, primarily due to higher concession supplies expense (19.5% of concession revenue vs. 17.6%) and increased general and administrative expenses. Operating income fell to $114.4 million (13.3% margin) from $163.5 million (17.7% margin).
U.S. Markets: Revenue decreased 7.8% to $683.6 million. Attendance fell 11.7% to 33.2 million patrons, but average ticket price rose 5.2% to $10.50 and concession revenue per patron increased 2.9% to $8.20. Film rentals and advertising costs improved to 58.4% of admissions revenue from 59.2%, reflecting a lower concentration of high-grossing films. Salaries and wages decreased 2.6% due to lower attendance and labor productivity initiatives.
International Markets: Reported revenue declined 3.6% to $173.9 million, but on a constant currency basis, total revenue grew 5.3% to $190.0 million. Attendance decreased 7.9% to 21.0 million patrons. Constant currency average ticket price increased 13.4% to $4.24 and concession revenue per patron rose 11.8% to $3.32, driven by inflationary pricing actions. Other revenue increased 13.5% in constant currency due to inflationary impacts, higher loyalty program revenue, and increased transactional fees.
Management noted that the success of the theatrical exhibition industry remains contingent on the volume and box office performance of new film content, which is continuing to recover from the effects of the COVID-19 pandemic and the Hollywood strikes. The company highlighted inflationary pressures and tariffs impacting product costs, as well as labor market conditions driving wage rate increases. Recent developments include a $300 million share repurchase program approved on October 30, 2025, and an increase in the annual cash dividend from $0.32 to $0.36 per share, effective for the next quarterly dividend payment. The company believes existing cash and expected cash flows from operations will be sufficient to meet working capital, capital expenditures, and contractual obligations for the next twelve months and beyond.
As of September 30, 2025, Cinemark held $461.3M in cash and cash equivalents, down from $1,057.3M at December 31, 2024, primarily due to debt repayments and share repurchases. Total debt (including current portion) stood at $1,898.9M, a reduction of $464.8M from year-end 2024, driven by the cash settlement of the $460.0M 4.50% Convertible Senior Notes in August 2025. Shareholders' equity was $392.4M, down from $603.4M, reflecting $200M in stock repurchases and dividend payments. The company also reported $558.8M in deferred revenue (including NCM advertising advances).
Cinemark disclosed $43.4M in signed but not yet commenced theater and facility lease payments as of September 30, 2025. These commitments are contingent on construction completion and are not yet recorded on the balance sheet. Additionally, NCM screen advertising advances of $310.1M represent a long-term financing component with a weighted average recognition period extending to 2041.
On March 6, 2025, the Board authorized a $200.0M share repurchase program, which was completed within the month, reducing outstanding shares by ~7.93M. Dividends were reinstated at $0.08 per share quarterly ($0.32 annualized), with $29.0M recorded in the first nine months of 2025. Net debt decreased by $464.8M due to the conversion note repayment and minimal new borrowings. Capital expenditures totaled $105.6M (4.5% of revenue), focused on theater upgrades and maintenance.
Cinemark operates two reportable segments: U.S. and International. For the nine months ended September 30, 2025, the U.S. segment generated $1,860.0M in revenue (up 5.1% YoY) and Adjusted EBITDA of $348.3M. International revenue was $478.7M (up 3.0% YoY) with Adjusted EBITDA of $97.9M. The U.S. segment contributed 80% of total revenue and 78% of segment EBITDA. International operations span 13 Latin American countries, with Brazil being the largest market. Note that the company uses Adjusted EBITDA as its primary segment profit measure.
The provided text does not include the actual cash flow statement. Based on the notes, Cinemark repurchased $200.0 million of stock in March 2025, funded by cash on hand. Stock-based compensation expense (non-cash) totaled $12.6 million for restricted stock, $1.0 million for RSUs, and $12.5 million for PSUs during the nine months ended September 30, 2025. No operating, investing, or financing cash flow figures are available for analysis.